The Forbes Interview

Vivek Ramaswamy: Developing Drugs For Neglected Diseases

Founder and CEO of Roivant Sciences, 31-year-old Vivek Ramaswamy, goes deep into the workings of the pharmaceutical industry. He explores questions including: Why take on Alzheimers when other big pharmaceuticals aren't? Why have there been so few changes in drug development for women's health? And why he's willing to take the financial risk of investing in drug research that fails.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

<p>Host Steven Bertoni, VP and Senior Editor of Under 30 brings you in-depth conversations with rising entrepreneurs, established leaders and the most significant minds influencing the business world today. From the origins of ideas, to the challenges of responsible growth, corporate governance, what informs success, the drive to succeed and everything in between. These are the behind-the-scene stories and personal anecdotes of the people that took their big ideas and made them a reality.</p>